Stock listing

LUNB Stock Price, News, Filings & Events — H. Lundbeck A/s Class A

Selected listing: LUNB · VIE · EUR · AT

This page tracks H. Lundbeck A/s Class A's LUNB:VIE listing on VIE in EUR for AT, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LUNB:VIE. LUNB:VIE is the stock-level entry point for investors researching H. Lundbeck A/s Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. H. Lundbeck A/s Class A is a public company based in Denmark, focusing on pharmaceuticals, particularly in the field of mental health. The company has a market capitalization of approximately 5.07 billion USD. Lundbeck is known for its commitment to developing innovative treatments for psychiatric and neurological disorders.

LUNB:VIEEURATUpdated August 28, 2026
H. Lundbeck A/s Class A logo
Ticker
LUNB:VIE
Asset type
Stock
Market cap
$5.17B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
VIE
Currency
EUR

H. Lundbeck A/s Class A LUNB:VIE stock context

This page tracks H. Lundbeck A/s Class A's LUNB:VIE listing on VIE in EUR for AT, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LUNB:VIE. LUNB:VIE is the stock-level entry point for investors researching H. Lundbeck A/s Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. H. Lundbeck A/s Class A is a public company based in Denmark, focusing on pharmaceuticals, particularly in the field of mental health. The company has a market capitalization of approximately 5.07 billion USD. Lundbeck is known for its commitment to developing innovative treatments for psychiatric and neurological disorders.

Latest news from H. Lundbeck A/s Class A

All H. Lundbeck A/s Class A news →

H. Lundbeck A/s Class A earnings calls

Research H. Lundbeck A/s Class A

Alternate listings